Skip to main content
. 2009 Oct 1;2009:0406.
Ref (type) Population Outcome, Interventions Results and statistical analysis Effect size Favours
Eradication rates

Systematic review
906 people
7 RCTs in this analysis
Eradication rates
339/470 (72%) with 7-day treatment with proton pump inhibitor-based triple regimens
353/436 (81%) with 14-day treatment with proton pump inhibitor-based triple regimens

RR 0.89
95% CI 0.83 to 0.96
NNT 11
95% CI 7 to 33
Small effect size 14-day treatment

RCT
3-armed trial
909 people with H pylori infection and duodenal ulcer Eradication rates 4 weeks
240/301 (80%) with 7-day treatment with proton pump inhibitor-based triple regimen
246/301 (82%) with 14-day treatment with proton pump inhibitor-based triple regimen

P = 0.53
The RCT adjusted results to allow for multiple comparisons
Not significant

RCT
598 people with H pylori infection and peptic ulcer disease Eradication rates 5 weeks
240/337 (71%) with 7-day treatment with proton pump inhibitor-based triple regimen
197/261 (76%) with 14-day treatment with proton pump inhibitor-based triple regimen

ARR −4%
95% CI −11% to +3%
RCT designed as an equivalence trial; the high predetermined non-inferiority margin of 15% means that the results must be treated with caution
Not significant

RCT
243 people with H pylori infection and dyspepsia having amoxicillin-based triple eradication therapy
Subgroup analysis
Eradication rates
67/117 (57%) with 7-day treatment with amoxicillin-based triple regimen
88/126 (70%) with 14-day treatment with amoxicillin-based triple regimen

P = 0.05
Result is of borderline significance
A multivariate analysis found that the 2-week duration of treatment was the only independent factor associated with a higher rate of H pylori eradication both at ITT and per-protocol analysis
Not significant

RCT
243 people with H pylori infection and dyspepsia having metronidazole-based triple eradication therapy
Subgroup analysis
Eradication rates
63/122 (52%) with 7-day treatment with metronidazole-based triple regimen
68/121 (56%) with 14-day treatment with metronidazole-based triple regimen

Significance not assessed
A multivariate analysis found that the 2-week duration of treatment was the only independent factor associated with a higher rate of H pylori eradication both at ITT and per-protocol analysis